Health Care & Life Sciences » Biotechnology | Human Metabolome Technologies Inc.

Human Metabolome Technologies Inc. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
5,962.00
21,895.00
73,423.00
40,410.00
149,173.00
356,080
Depreciation, Depletion & Amortization
36,501.00
71,148.00
61,462.00
53,245.00
61,470.00
63,683
Other Funds
10,416.00
7,152.00
10,272.00
11,144.00
3,886.00
30,065
Funds from Operations
52,879.00
42,101.00
1,689.00
23,980.00
91,589.00
262,332
Changes in Working Capital
23,311.00
24,286.00
56,339.00
21,219.00
86,607.00
46,988
Net Operating Cash Flow
29,568.00
66,387.00
58,028.00
45,199.00
178,196.00
215,344
Capital Expenditures
35,869.00
104,266.00
18,759.00
34,998.00
89,357.00
Sale of Fixed Assets & Businesses
-
-
-
-
3,000.00
Purchase/Sale of Investments
-
6,342.00
102,793.00
-
-
Net Investing Cash Flow
39,986.00
97,924.00
124,423.00
34,205.00
87,170.00
Issuance/Reduction of Debt, Net
42,429.00
83,356.00
36,572.00
28,024.00
9,282.00
Net Financing Cash Flow
1,314,396.00
17,283.00
28,028.00
354,660.00
4,907.00
Net Change in Cash
1,307,217.00
46,196.00
210,666.00
367,818.00
258,961.00
Free Cash Flow
2,749.00
36,933.00
76,100.00
13,596.00
262,715.00
Other Sources
228.00
-
-
792.00
-
Change in Capital Stock
1,356,825.00
66,073.00
8,544.00
382,685.00
14,190.00
Exchange Rate Effect
3,239.00
2,624.00
187.00
2,164.00
1,498.00
Other Uses
4,345.00
-
2,871.00
-
812.00

About Human Metabolome Technologies

View Profile
Address
246-2 Mizukami, Kakuganji
Tsuruoka Yamagata 997
Japan
Employees -
Website http://humanmetabolome.com
Updated 07/08/2019
Human Metabolome Technologies, Inc. engages in diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.